Ductal Carcinoma of the Breast
📧 Sign up to get email alerts when something new happens for Ductal Carcinoma of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer [Phase 2]
Phase II randomized trial comparing baby exemestane to baby tamoxifen in post-menopausal women at high risk for breast cancer (not yet recru…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer [NA]
An update on a clinical trial evaluating accelerated partial breast irradiation after lumpectomy for breast cancer, with the trial currently…
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC [NA]
Clinical trial update reporting spect analysis of cardiac perfusion changes after whole-breast/chest-wall radiation therapy using ABC.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast [NA]
A completed clinical trial update examining radiation therapy planning techniques to minimize normal-tissue damage during breast-conserving …
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy [Phase 4]
This update reports the completion of a Phase 4 trial evaluating autologous fat grafts enriched with regenerative cells to reconstruct breas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-01Clinical Trial Update: Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 study evaluated pemetrexed as first-line therapy for advanced or metastatic breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating docetaxel plus doxorubicin for breast cancer has been terminated.